MedTrace Logo

Heparin Alone vs. Heparin-Aspirin Combo in Free Flap Survival

NCT06512233 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 126

Last updated 2024-07-23

No results posted yet for this study

Summary

This randomized clinical trial aims to compare the effectiveness of heparin alone versus combination therapy of Heparin- Aspirin in improving free flap survival in patients undergoing reconstructive surgery. Participants will be randomly assigned to receive either heparin or a combination therapy, and the primary outcome measure will be the survival rate of the free flap at various time points post-surgery

Conditions

  • Complication,Postoperative

Interventions

DRUG

LMW Heparin 5000 U/ML-Aspirin 75 MG

Arm 1

DRUG

LMW Heparin 5000 U/ML

Arm 2

Sponsors & Collaborators

  • Aga Khan University

    lead OTHER

Principal Investigators

  • Fizzah Arif, MD · Aga Khan University

  • Fazlur Rahman, MD · Aga Khan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-31
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06512233 on ClinicalTrials.gov